Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eczematous component in psoriasis is possibly a negative prognostic factor for deucravacitinib treatment outcome.

Dermatology (Basel, Switzerland)·2026
Same author

Trust in skincare and topical therapies in atopic dermatitis or psoriasis: a German cross-sectional study.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same author

Insights into Api m 10-Isoforms and Splice Variants: More Than One Major IgE-Binding Epitope.

Clinical and translational allergy·2026
Same author

HLA-G, IL-6 and TGF-β in Seminal Plasma as Potential Biomarkers of ART Outcome.

American journal of reproductive immunology (New York, N.Y. : 1989)·2025
Same author

Treatment Preferences Among Systemic Therapy-Naïve Patients with Atopic Dermatitis or Psoriasis in Germany: A Multicentre Study.

Dermatology and therapy·2025
Same author

Anifrolumab has a direct immunoregulatory effect on inflamed keratinocytes: implications for the treatment of lupus erythematosus skin lesions.

Frontiers in immunology·2025

Related Experiment Video

Updated: Jun 20, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Dendritic cells as potential targets for mucosal immunotherapy.

Jean-Pierre Allam1, Thomas Bieber, Natalija Novak

  • 1Department of Dermatology and Allergy, University of Bonn, Bonn, Germany.

Current Opinion in Allergy and Clinical Immunology
|September 12, 2009
PubMed
Summary

Sublingual immunotherapy (SLIT) is effective for allergic rhinitis. Oral mucosal dendritic cells (oDCs) are key to SLIT

More Related Videos

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

Related Experiment Videos

Last Updated: Jun 20, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

Area of Science:

  • Immunology
  • Allergy Research
  • Oral Mucosal Immunology

Background:

  • Sublingual immunotherapy (SLIT) is a safe and effective alternative to subcutaneous immunotherapy for allergic rhinitis.
  • The precise immunological mechanisms underlying SLIT's efficacy are not fully understood.
  • Oral mucosal antigen-presenting cells, particularly dendritic cells (DCs), are hypothesized to play a crucial role in initiating and regulating T-cell responses during SLIT.

Purpose of the Study:

  • To investigate the role of oral mucosal dendritic cells (oDCs) in the immunological mechanisms of sublingual immunotherapy.
  • To explore the potential of oDCs in modulating T-cell activation and inducing tolerance in the context of allergic rhinitis treatment.

Main Methods:

  • Analysis of antigen processing capabilities of oral mucosal dendritic cells (oDCs).
  • Assessment of the in vitro immunomodulatory properties of oDCs activated by various antigens and adjuvants.
  • Investigation of oDC distribution within different regions of the oral cavity.

Main Results:

  • Oral mucosal dendritic cells (oDCs) can process antigens applied to mucosal surfaces.
  • oDCs exhibit a natural pro-tolerogenic character, inducing tolerogenic T cells.
  • Higher numbers of oDCs are found in the oral vestibular region compared to the sublingual region.

Conclusions:

  • Oral mucosal dendritic cells (oDCs) possess inherent pro-tolerogenic properties crucial for successful sublingual immunotherapy.
  • Understanding oDC behavior may lead to novel SLIT strategies, including the use of adjuvants.
  • Exploring alternative allergen application sites, like the oral vestibule, could enhance SLIT efficacy.